Submitted by Anonymous (not verified) on 29 January 2026 - 15:30
Human medicines European public assessment report (EPAR): Spinraza, nusinersen, Date of authorisation: 30/05/2017, Revision: 20, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Spinraza, nusinersen, Date of authorisation: 30/05/2017, Revision: 20, Status: Authorised